Navigation Links
Nutralife Hails New Study’s Findings on SAM-e, Giving Hope to Millions Seeking Joint Relief
Date:4/4/2013

Lakewood,NJ (PRWEB) April 04, 2013

The popular supplement S-Adenosyl Methionine, commonly known as SAMe received the highest rating for all supplements in a recent report evaluating the efficacy of many supplements taken for osteoarthritis. Once again this study reiterates the value of SAMe and offers significant hope for the 27 million plus Americans who suffer from osteoarthritis on a daily basis.

In the report released by Arthritis Research UK, a major medical research organization in England, researchers evaluated 31 complementary medicines taken either by mouth or applied to the skin that were found to have quality studies available. Each was scored for effectiveness based on users’ improvements in pain, disability or quality of life on a scale of 1 to 5, with “1” suggesting the lowest degree of efficacy and “5” suggesting the highest. SAMe received a 4, the highest rating of all the supplements for arthritis relief.

“The results of this study are not surprising to us,” stated Abigail Glass, President and Founder of Nutralife Health Products (NHP), a New Jersey based company that has been distributing SAMe supplements for over a decade. “Our customers have constantly been reporting back to us that SAMe has helped rejuvenate their joints, like no other supplement.” According to the Textbook of Natural Medicine (Michael T. Murray, 2006), a total of 21,524 patients with osteoarthritis have utilized SAMe in detailed clinical trials. In double-blind trials, SAMe has demonstrated similar reductions in pain scores and clinical symptoms to those produced by nonsteroidal anti-inflammatory drugs (NSAIDs) and was found to be generally much better tolerated.

“We are pleased that the benefits and scientific evidence of the efficacy of SAMe has been reiterated,” says Ephraim Glass, VP of Marketing at Nutralife Health Products. “Because of the staggering amount of consumers suffering from osteoarthritis, it is important that they are able to make informed decisions about the supplements they purchase.” There are 27 million people in the United States who suffer from osteoarthritis, and the number is on the rise according to a recent CDC report. According to a US government report released in 2013 by the AHRQ (Agency for Healthcare Research and Quality), a division of the National Institute of Health; Osteoarthritis was the most common diagnosis among adults ages 45-84 in 2010.

“We know that SAMe is truly a unique product,” says Sarah Levi, VP of Research and Development at Nutralife Health Products. “SAMe has been around for decades, has been the subject of numerous clinical trials and reviews, and is time and again proven effective.”

Nutralife Health Products introduced SAMe into the United States in the 1990s, and it remains a leading brand in SAMe distribution. NHP’s SAMe is available in 200mg and 400mg doses and contain the trademarked (S)SAMe, Nutralife’s proprietary SAMe raw material.

Nutralife has always been at the forefront of SAMe research. “We hope that by promoting consumer awareness, many more people will realize the benefits of SAMe,” stated Abigail Glass.

To see the full report by Arthritis Research UK, see the following link: http://www.arthritisresearchuk.org/arthritis-information/complementary-and-alternative-medicines/complementary-and-alternative-medicines.aspx

About NutraLife™ Health Products:

NutraLife™ Health Products (NHP), a women-owned business, was founded in 1996 by two women with one goal: to provide health-conscious individuals with natural, safe, and clinically-proven dietary supplements. NHP features a complete line of vitamins and supplements under the NutraLife™ brand. NutraLife™ SAMe products are among the leading selling SAMe SKU’s in the nutritional supplement category according to IRI, and can be found at prominent retailers such as Walgreens and CVS.

To find out more about Nutralife SAMe, please contact Nutralife Health Products.

Nutralife Health Products
1-877-688-7254
http://www.nutralifesame.com
http://www.joint-rite.com

Read the full story at http://www.prweb.com/releases/2013/4/prweb10555295.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Nutralife Health Products Inc. Announces Launch of New Website for its Revolutionary Joint Supplement, JointRite
2. New England Journal of Medicine hails new skin cancer drug as greatest advance yet
3. New findings in breast cancer
4. Kessler Foundation scientists present cognitive research findings at MS dual symposium
5. Researchers present new findings for novel pancreatic cancer vaccine
6. Mayo Clinic urologists present findings at American Urological Association Annual Meeting
7. Once-Banned Bird Flu Study Yields Sobering Findings
8. Columbus Allergist Dr. Summit Shah Discusses Recent Findings on Food Allergies and Exercise-Induced Anaphylaxis
9. Relief for Migraine Sufferers as The Life House Offers New Findings, Free Consults
10. New findings by GW researcher break tanning misconceptions: There is no such thing as a safe tan
11. MRI findings shed light on multiple sclerosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... , ... March 28, 2017 , ... ... plans work, the Self-Funding Success website has recently developed and published an informational ... Plans ” was created based on common inquiries the site’s team of third ...
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... ... Liu of SkyLex Advanced Surgical, Inc. is thrilled to offer the recently FDA-approved ... procedure, and this procedure adds to SkyLex Advanced Surgical’s already comprehensive list ...
(Date:3/28/2017)... ... 28, 2017 , ... Oily skin is a common and unwelcomed occurrence in people of all ... lot to offer to the discussion of dealing with excess skin oil. “Oily skin is ... home remedies that can help remove the oily shine while keeping the skin fresh and ...
(Date:3/27/2017)... Aurora, CO (PRWEB) , ... March 27, 2017 , ... ... Dr. Mark Braasch for leading sleep apnea treatment, with or without a referral. Sleep ... the condition, which can include daytime sleepiness, morning headaches and chronic snoring. , ...
(Date:3/27/2017)... ... March 27, 2017 , ... Biotechnology and ... and engagement over the household brands of Top-20 pharma by optimizing clinical trial ... partnering with the right outsourcing payments provider can provide the technology, infrastructure, and ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... Elysium Health joins major pharmaceutical companies to ... Cambridge academic scientists through ... Institute today announces Elysium Health as a partner to the ... collaborative projects with academic researchers in Cambridge ... major research investment outside the U.S. for the ...
(Date:3/27/2017)... 27, 2017 Summary This ... Eli Lilly and its partnering interests and activities since 2010. ... provides an in-depth insight into the partnering activity of one ... demand company reports are prepared upon purchase to ensure inclusion ... The report will be delivered in PDF format ...
(Date:3/27/2017)... -- ImMAGE Biotherapeutics (OTCMKTS: IMMG), an early-stage biotechnology company, announced ... efficacy studies. The company is harnessing the power of ... A, in an effort to find a better treatment ... 4 weeks of treatment in transgenic mice, the lead ... a full toxicology report of various organs. Cytotoxic T-cells ...
Breaking Medicine Technology: